(BPMC) Blueprint Medicines complete technical analysis [charts+indicators] | Buy/Sell Blueprint Medicines | (BPMC) share price targets
Complete technical analysis of Blueprint Medicines (BPMC) by charts plus indicators, forecast predictions and share price targets for Blueprint Medicines (BPMC)
Blueprint Medicines trades in USA in Health Care sector.
Showing technical analysis as on 2024-11-15 View latest technical analysis
10 day averaged volume of Blueprint Medicines is 617320
Date | Daily Closing Price | Open | High | Low | Volume |
15 Fri Nov 2024 | 88.69 | 96.34 | 96.34 | 88.41 | 1.622 times |
14 Thu Nov 2024 | 95.65 | 99.18 | 100.01 | 95.46 | 0.764 times |
13 Wed Nov 2024 | 96.88 | 98.00 | 100.23 | 96.83 | 0.593 times |
12 Tue Nov 2024 | 96.62 | 98.60 | 100.85 | 96.52 | 0.733 times |
11 Mon Nov 2024 | 99.87 | 102.07 | 103.55 | 99.41 | 0.737 times |
08 Fri Nov 2024 | 100.83 | 101.58 | 101.97 | 98.95 | 1.012 times |
07 Thu Nov 2024 | 101.39 | 99.33 | 102.47 | 98.59 | 1.131 times |
06 Wed Nov 2024 | 99.63 | 100.00 | 101.48 | 98.41 | 1.564 times |
05 Tue Nov 2024 | 97.55 | 91.00 | 97.67 | 91.00 | 1.521 times |
04 Mon Nov 2024 | 91.88 | 90.70 | 93.00 | 89.50 | 0.94 times |
My analysis of stock is bearish for shortterm, and stock might move down till 84.7 or till 76.8. Use a stoploss of 91.23 and if the stock hits stoploss, then it can shoot up till 97.8
Share price targets for Blueprint Medicines (BPMC)
Target Type | Value |
Downside Target | 80.68 |
Downside Target | 83.91 |
Downside Target | 87.24 |
Upside Target | 94.98 |
Upside Target | 96.50 |
Upside Target | 102.47 |
Upside Target | 103.55 |
Upside Target | 106.56 |
Upside Target | 108.40 |
Upside Target | 121.90 |
Intraday share price targets for Blueprint Medicines (BPMC)
Target Type | Value |
Downside Intraday Target | 83.55 |
Downside Intraday Target | 78.41 |
Upside Intraday Target | 98.69 |
Upside Intraday Target | 108.69 |
Upside Intraday Target | 93.55 |
Weekly technical analysis of Blueprint Medicines (BPMC)
Date | Weekly Closing Price | Open | High | Low | Volume |
15 Fri Nov 2024 | 88.69 | 102.07 | 103.55 | 88.41 | 0.721 times |
08 Fri Nov 2024 | 100.83 | 90.70 | 102.47 | 89.50 | 0.733 times |
01 Fri Nov 2024 | 90.70 | 83.33 | 94.98 | 80.68 | 1.761 times |
25 Fri Oct 2024 | 82.47 | 85.78 | 87.24 | 81.22 | 1.174 times |
18 Fri Oct 2024 | 86.00 | 87.61 | 91.16 | 85.12 | 1.085 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Blueprint Medicines (BPMC)
Date | Monthly Closing Price | Open | High | Low | Volume |
15 Fri Nov 2024 | 88.69 | 87.53 | 103.55 | 87.28 | 0.494 times |
31 Thu Oct 2024 | 87.51 | 91.63 | 94.98 | 80.68 | 1.055 times |
30 Mon Sep 2024 | 92.50 | 94.80 | 96.50 | 83.91 | 0.853 times |
30 Fri Aug 2024 | 95.54 | 106.51 | 108.40 | 89.35 | 1.157 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Blueprint Medicines (BPMC)
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Blueprint Medicines stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Blueprint Medicines in short term but the sell signal is initial and weak.
Blueprint Medicines Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Blueprint Medicines in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Blueprint Medicines is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 96.65 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Blueprint Medicines stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Blueprint Medicines in short term but the sell signal is initial and weak.
Blueprint Medicines Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Blueprint Medicines in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Blueprint Medicines is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 96.65 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.